Loozy logo

Loozy Review

6.6
★★★☆☆3.3/5

Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.6/10

Best for: people who want semaglutide or tirzepatide on a 3-month plan from a brand that names its doctors and pharmacy

Price is where Loozy scores best in our breakdown.

Semaglutide

$149/mo · 3-month plan rate

Tirzepatide

$216/mo · 3-month plan rate
Price rises with dose

Price checked on Loozy’s site,

What the monthly price covers

Medication

Included

Provider visits

Included

Shipping

Not stated

Lab work

Not stated

Coaching

Billed separately

See plans →

No insurance neededVetted by our editors

Compare top-rated alternatives ↓

Loozy is a casual-toned telehealth brand selling compounded semaglutide and tirzepatide as a 3-month membership paid upfront, with prescribing by Elite Care Health and fulfillment by Rx Ave Health. Semaglutide starts at $199/mo ($597 per 3 months) and tirzepatide at $249/mo ($747); lower-cost microdosing plans exist, and the price rises when you move to higher doses.

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
CompoundedSemaglutideTirzepatideMicrodosing3-Month MembershipAsync MessagingHSA/FSA Eligible

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money

Vetted alternatives to Loozy

7.7/ 10
Partner

Ro

Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help

★★★★☆3.9/5

Editorial score · methodology

$149/mosemaglutide
+ required membership
BrandSemaglutideTirzepatideOrforglipron
Get StartedRead full Ro review →
8.3/ 10
Partner

Collective

Best for: the lowest flat medication price if you can absorb an annual membership fee

★★★★☆4.2/5

Editorial score · methodology

$59/mosemaglutide
+ required membership
$69/motirzepatide
+ required membership
CompoundedSemaglutideTirzepatide
Get StartedRead full Collective review →
8.3/ 10
Partner

CoreAge Rx

Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose

★★★★☆4.2/5

Editorial score · methodology

$79/mosemaglutide
“starting at” price
$129/motirzepatide
“starting at” price
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript Verified
Get StartedRead full CoreAge Rx review →
Loozy logo
3.3 / 5
Our editorial rating
Visit Loozy →

from $149/mo (3-month plan rate) · no insurance needed

Loozy at a glance

Type
GLP-1 telehealth provider
Medications
Semaglutide, Tirzepatide
Starting price
$149/mo (3-month plan rate) (Listed in the intake plan menu as "$447 for 3 months." Fixed low dose.)
Pricing model
Scales with dose: higher doses cost more
What's included
Medication · Consult
FDA status
No FDA warning letter on record

How we scored Loozy

Each dimension is scored algorithmically from Loozy’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.

Value25%

7.1/10

At $149/mo (3-month plan rate), Loozy runs about 17% below the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide). Note the price scales with dose, so budget for higher tiers as you titrate.

Effectiveness25%

7.1/10

Loozy offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.

User Experience15%

6.8/10

Online intake and platform experience (ongoing clinician messaging, consult included in the price); 7 platform features disclosed.

Trust & Safety15%

6.3/10

Core details confirmed by our editors; no FDA warning letters on file.

Accessibility10%

5.5/10

Loozy's exact state footprint isn't published. Confirm coverage in your state before signing up. FSA/HSA cards are accepted.

Support10%

5.0/10

Coaching not included in the base price, clinician messaging between visits.

6scored dimensions
671providers compared

Each checked against the provider’s own site.

Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →

How we verified this Loozy review

Last checked September 2026
  • Confirmed current pricing across 7 dose/plan tiers
  • Confirmed what the monthly price does and doesn't include
  • Checked the FDA warning-letter database for enforcement actions
  • Walked the provider's public sign-up flow, stopping before payment

Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.

What we checked

Provider's own pricing page
$149–$370/mo across 7 dose/plan tiers (checked September 2026)
FDA warning-letter register
No letter on file for this provider

What to expect when you sign up with Loozy

We walked Loozy’s public signup flow in September 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)

  1. 1Tap "get started" on the homepage, which opens the intake on a separate start page
  2. 2Pick your health goals, sex at birth, date of birth, height, current weight and goal weight
  3. 3Choose your state
  4. 4A "Before we continue" pop-up asks for first and last name, email, phone and SMS consent (walk stopped here)
  5. 5Per the intake's own page list, next come pregnancy, conditions, medications, allergies, alcohol and GLP-1 history questions, then consent, plan choice, shipping, checkout and a government ID upload
Price shown before you start
  • The homepage shows only the semaglutide starting price ($199/mo billed as a 3-month plan); tirzepatide and microdosing prices sit inside the intake
  • The contact pop-up checks that your email can receive mail and rejected both a placeholder address and a disposable inbox
  • Every plan is billed as a 3-month block, and the plan for your next block costs more once you move past the starter doses
  • Patients in Arkansas, DC, Kansas, Mississippi, New Jersey, New Mexico, Rhode Island, Virginia and West Virginia are routed to a scheduled video call before a prescription
  • A government ID upload is required after checkout
  • Homepage testimonials are labeled "illustrative composites, not verified outcomes"
  • We did not take the medication, and nothing here describes a patient outcome

Loozy customer support

Email
support@loozy.care

GLP-1 medications Loozy offers

Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.

SemaglutideTirzepatide

Pricing

Prices re-verified

Starter plan (0.225mg → 0.45mg → 0.9mg), 3-month prepay, $597 charged upfrontCompounded
$199/mo
semaglutide

Homepage: "$199/mo, billed as a 3-month plan." Membership includes the consult.

Continuation or Maintenance plan (0.9mg → 2.25mg), 3-month prepay, $657 upfrontCompounded
$219/mo
semaglutide

The next 3-month block after Starter costs $657.

Microdosing plan (0.225mg for 3 months), 3-month prepay, $447 charged upfrontCompounded
$149/mo
semaglutide

Listed in the intake plan menu as "$447 for 3 months." Fixed low dose.

Starter plan (2.1mg → 4.25mg → 6.5mg), 3-month prepay, $747 charged upfrontCompounded
$249/mo
tirzepatide

Tirzepatide pricing appears only inside the intake, not on the homepage.

Continuation plan (8.5mg → 13.5mg), 3-month prepay, $998 charged upfrontCompounded
$333/mo
tirzepatide

$998 per 3 months, about $332.67/mo.

Maintenance plan (13.5mg for 3 months), 3-month prepay, $1,110 charged upfrontCompounded
$370/mo
tirzepatide

$1,110 per 3 months.

Microdosing plan (2.1mg for 3 months), 3-month prepay, $647 charged upfrontCompounded
$216/mo
tirzepatide

Listed in the intake plan menu as "$647 for 3 months," about $215.67/mo.

Ready to get started?

Plans and promotions change often, so check Loozy's current pricing and active discounts before you decide.

See Loozy pricing →

What we like

  • Names its medical group (Elite Care Health) and its pharmacy (Rx Ave Health), which many brands never disclose
  • Semaglutide starts at $199/mo on a 3-month plan, with a $149/mo microdosing option
  • Membership covers the provider review, dose titration, medication and unlimited async messaging
  • Full refund if you cancel before a provider reviews your intake; $59 kept if you are not approved
  • Cash-pay with HSA/FSA use suggested, so no insurance paperwork
  • Offers both compounded semaglutide and tirzepatide, plus low-dose microdosing plans

Watch-outs

  • No month-to-month option: every plan is a 3-month membership charged in full upfront
  • Price rises as you move up in dose: semaglutide goes from $597 to $657 per 3 months, tirzepatide from $747 to $1,110
  • Tirzepatide prices are not on the homepage; you only see them inside the intake
  • You must give your name, email and phone before seeing plans, and throwaway emails are rejected
  • Membership fees are non-refundable once a provider has reviewed your intake, apart from the partial refunds in the policy
  • Homepage testimonials are labeled "illustrative composites," not real patient reviews
  • State coverage is described three different ways and no state list is published
  • Support is email-only; no phone number is published

Is Loozy worth it?

Loozy is built for people who want semaglutide or tirzepatide on a 3-month plan from a brand that names its doctors and pharmacy. It runs $149/month (3-month plan rate). That is a qualified figure, not a plain month-to-month price, so we don't rank it against the category median; the cost section below says what it covers. No single feature of its GLP-1 program sets it apart from the category on its own, so the price and terms below are the things to compare.

On top of the core program, it offers a microdosing option and takes HSA/FSA payment.

How much Loozy costs

Compounded semaglutide runs $199–$219/month depending on plan, the low end a 3-month plan rate, and compounded tirzepatide runs $249–$370/month depending on plan, the low end a 3-month plan rate.

Because Loozy's headline figure is a 3-month plan rate, we don't set it against the roughly $179 market median for this category. That median is each program's lowest listed ongoing monthly price for compounded semaglutide, so compare Loozy with the month-to-month prices of the alternatives below instead.

PlexusDx (about $149/month) is one of the closest alternatives to weigh Loozy against.

Medications: what Loozy prescribes

Loozy prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro), the two molecules with the strongest published weight-loss trial outcomes. These are dispensed as compounded formulations from a licensed pharmacy, which is how the price stays below brand-name pens. Compounded drugs aren't FDA-approved as finished products, which is the standard trade-off across the compounded-GLP-1 market.

Who Loozy is best for, and who should skip it

A good fit if you…

  • value being able to message a clinician between visits instead of waiting on the next scheduled one.

Look elsewhere if you…

  • specifically want an FDA-approved brand-name pen instead of a compounded formulation, which this provider doesn't fill.
  • need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.

Trust, safety, and medical oversight

Loozy offers clinician messaging between visits, and we found no FDA warning letter on file for it. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation, and we explain how in our scoring methodology.

Bottom line

Loozy is a reasonable telehealth GLP-1 option; weigh its pricing and coverage against the alternatives below before deciding. To see Loozy against the wider field, use our ranking of semaglutide providers; the patient guide to compounded versus brand-name GLP-1s covers what to weigh before choosing a compounded program.

The Bottom Line

Price is where Loozy scores best in our breakdown.

Score: 6.6/10Best for: people who want semaglutide or tirzepatide on a 3-month plan from a brand that names its doctors and pharmacyFrom: $149/mo (3-month plan rate)

Ready to start with Loozy?

From $149/mo (3-month plan rate). See current pricing and start your free consultation.

Visit Loozy →

Loozy might not be your best fit if…

We rank editorially, so here’s where a different provider we track may serve you better.

  • If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider altRX.
  • If the lowest possible monthly price is your top priority, consider YourEra (from $89/mo).
  • If you want built-in coaching and behavior-change support, consider Ro.
See all alternatives to Loozy →

Head-to-head

Compare Loozy vs…

Loozy scores6.6/10

Side-by-side pricing, medications and scores. Pick a matchup.

Scores are our independent editorial ratings out of 10.

Frequently Asked Questions

Loozy is a casual-toned telehealth brand selling compounded semaglutide and tirzepatide as a 3-month membership paid upfront, with prescribing by Elite Care Health and fulfillment by Rx Ave Health. Semaglutide starts at $199/mo ($597 per 3 months) and tirzepatide at $249/mo ($747); lower-cost microdosing plans exist, and the price rises when you move to higher doses. We scored it 6.6/10 across our six-dimension editorial framework.
Loozy is an operating telehealth provider, and we found no FDA warning letter on file for it. We could not confirm a LegitScript certification from its public pages. We last checked its prices and policies on its own site in September 2026. We scored it 6.6/10 from published information, which is not a clinical endorsement. Talk to a licensed clinician before starting any medication.
Loozy starts at $149/month (3-month plan rate). Pricing scales with your dose, so higher doses cost more. See the pricing table above for every tier.
Loozy doesn't use public promo or coupon codes. Third-party sites advertising "Loozy discount codes" are typically fake; any current offer applies automatically through the link on this page.
Loozy hasn't published its exact state footprint. Confirm coverage in your state before signing up.
Loozy offers semaglutide (the active drug in Wegovy/Ozempic) and tirzepatide (the active drug in Zepbound/Mounjaro). These are dispensed as compounded formulations.
Loozy dispenses compounded GLP-1s made by a licensed compounding pharmacy, with the same active ingredient as the brand drugs at a lower cash price. Compounded drugs are not FDA-approved as finished products; we cover what that means in the review.
Loozy is a cash-pay program (no insurance required) and accepts FSA/HSA cards.
Loozy's price includes medication and the clinician consult. See the "what's included" strip near the top of this review.
You complete an online intake, a licensed clinician looks at whether a GLP-1 fits your situation, and, if you're approved, your medication ships to your door. You can begin the consultation directly on Loozy's site.
We don't collect customer complaints, so this covers what our own review found. There is no FDA warning letter on file for Loozy. The concerns our review flags: No month-to-month option: every plan is a 3-month membership charged in full upfront; Price rises as you move up in dose: semaglutide goes from $597 to $657 per 3 months, tirzepatide from $747 to $1,110; Tirzepatide prices are not on the homepage; you only see them inside the intake; You must give your name, email and phone before seeing plans, and throwaway emails are rejected. Weigh them before you sign up.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Sources

The primary regulatory filings and peer-reviewed studies cited throughout this Loozy review:

Sources & methodology (as of November 2026)
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
  7. 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  8. 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  9. 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
  10. 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  11. 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  12. 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.

See Loozy's current pricing

Plans from $149/mo (3-month plan rate). Start your free consultation to check eligibility and today's price.

Visit Loozy →